Antibody against -tubulin was obtained from Thermo Scientific (MA, USA)
Contact your GP, specialist, or clinical trial team promptly if you experience: A spreading rash , hives (urticaria), or widespread skin redness that develops after starting treatment Swelling of the face, lips, tongue, or throat , which may indicate angioedema a potentially serious allergic reaction requiring urgent assessment Difficulty breathing or swallowing alongside skin changes call 999 immediately , as this could indicate anaphylaxis Signs of infection at an injection site , including increasing warmth, pus, significant swelling, or fever Persistent or worsening skin symptoms that do not improve with basic self-care measures after one to two weeks Unexplained bruising or bleeding beyond what would be expected from a subcutaneous injection If you are unsure whether your symptoms require urgent attention, NHS 111 can provide guidance

2 Materials and methods 2.1 Experimental design The experiment was conducted at the experimental station of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute (FLI), in Braunschweig, Germany in accordance with the German Animal Welfare Act and permitted by the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, Oldenburg, Germany) (AZ33.19-42502-04-16/2378)
Semaglutide & Tirzepatide Weight Loss Programs in 2025: How Sprout Health is Redefining Telehealth Care UPDATE - Contact information has been updated on this release as of September 9, 2025 A remote-first, doctor-reviewed telehealth program offering access to personalized care plans and GLP-1 evaluations using semaglutide or tirzepatide
optional TB-500 in some vendor variants Target: Skin / soft-tissue repair pathways (component-dependent) Supports collagen synthesis and skin barrier function Research shows potential for reducing fine lines and improving skin texture May accelerate cutaneous wound healing These are commonly discussed research protocols not medical advice